» Articles » PMID: 12861145

Validation of Two Global Impression Questionnaires for Incontinence

Overview
Publisher Elsevier
Date 2003 Jul 16
PMID 12861145
Citations 310
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study was to assess the construct validity of two global assessment questions, the Patient Global Impression of Severity and of Improvement, in female patients with stress urinary incontinence.

Study Design: This was a secondary analysis of data from two double-blind, placebo-controlled studies that evaluated duloxetine for the treatment of predominant stress urinary incontinence in the United States (n = 1133 patients). Assessment variables included incontinence episode frequency, the Incontinence Quality of Life Questionnaire results, fixed volume (400 mL) stress pad test results, and the Patient Global Impression of Improvement and of Severity question results.

Results: Spearman correlation coefficients were 0.36, 0.20, and -0.50 among the Patient Global Impression of Severity question and incontinence episode frequency, stress pad test, and Incontinence Quality of Life Questionnaire results, respectively (all P <.0001). Mean incontinence episode frequency and median stress pad test results increased and mean Incontinence Quality of Life Questionnaire results decreased with increasing Patient Global Impression of Severity question severity levels. Similarly, significant (P <.0001) correlations were observed between the Patient Global Impression of Improvement question response categories and the three independent measures of improvement in stress urinary incontinence (0.49, 0.33, and -0.43 with incontinence episode frequency, stress pad test, and Incontinence Quality of Life Questionnaire results, respectively). As with the Patient Global Impression of Severity question, differences in mean changes for Incontinence Quality of Life Questionnaire and median percent changes for incontinence episode frequency and stress pad test among the Patient Global Impression of Improvement question response categories were highly significant (P <.0001). These relationships indicate appropriate and significant associations between the Patient Global Impression of Severity and of Improvement questions and the three independent measures of stress urinary incontinence severity and improvement, respectively.

Conclusion: The Patient Global Impression of Severity and of Improvement question responses were correlated significantly with incontinence episode frequency, stress pad test, and Incontinence Quality of Life Questionnaire measures, which established the construct validity of these two global assessment questions for baseline severity and treatment response, respectively.

Citing Articles

Pelvic floor muscle training with feedback or biofeedback for urinary incontinence in women.

Fernandes A, Jorge C, Weatherall M, Ribeiro I, Wallace S, Hay-Smith E Cochrane Database Syst Rev. 2025; 3:CD009252.

PMID: 40066950 PMC: 11895424. DOI: 10.1002/14651858.CD009252.pub2.


Efficacy of Two Modes of Transvaginal Temperature-Controlled Radiofrequency for Female Stress Urinary Incontinence.

Wang X, Xu Y, Song Y, Zheng X, Jiang X, Lin C Int Urogynecol J. 2025; .

PMID: 39945801 DOI: 10.1007/s00192-025-06065-6.


Lifestyle recommendations and pelvic floor muscle training with Knack maneuver for post-prostatectomy urinary incontinence: a randomized controlled trial.

Gerlegiz E, Akbayrak T, Gursen C, Yazici M, Bolat N, Akdogan B Support Care Cancer. 2025; 33(2):132.

PMID: 39888446 PMC: 11785613. DOI: 10.1007/s00520-025-09197-z.


Efficacy and Tolerance of the Tampsec Vaginal Tampon for Treating Stress Urinary Incontinence. A Randomized Controlled Trial.

Diez-Itza I, Cassado J, Martin A, Munoz E, Lopez-Herrero E, Bauset C Int Urogynecol J. 2025; .

PMID: 39883126 DOI: 10.1007/s00192-025-06060-x.


Predictive Factors for Poor Outcome after Laparoscopic and Open Colposuspension: A Comparative Analysis Using the BSUG Database.

Tan A, Latthe P Int Urogynecol J. 2025; .

PMID: 39777525 DOI: 10.1007/s00192-024-06032-7.